Abstract
Background
Radiation-associated angiosarcoma (RAAS) is a devastating disease occasionally observed in breast cancer patients treated with radiation. Due to its rarity, our knowledge—of disease risk factors, epidemiology, treatment, and outcome—is extremely limited. Therefore, we sought to identify clinicopathologic factors associated with local and distant recurrence and disease-specific survival (DSS).
Methods
Radiation-associated angiosarcoma was defined as pathologically confirmed breast or chest wall angiosarcoma arising within a previously irradiated field. A comprehensive search of our institutional tumor registry (1/1/93 through 2/28/11) was used to identify patients (n = 95 females). Patient, original tumor, RAAS treatment, and outcome variables were retrospectively retrieved and assembled into a database.
Results
The median follow-up for all RAAS patients was 10.3 (range, 2.4–31.8) years. The latency period following radiation exposure ranged from 1.4 to 26 (median, 7) years. One-year and 5-year DSS rates were 93.5 and 62.6 %, respectively. Reduced risk of local recurrence was observed in patients who received chemotherapy (P = 0.0003). In multivariable analysis, size was found to be an independent predictor of adverse outcome (P = 0.015).
Conclusions
Our study demonstrates that RAAS exhibits high recurrence rates. It also highlights the need for well-designed, multicenter, clinical trials to inform the true utility of chemotherapy in this disease.
Similar content being viewed by others
References
Cahan WG, et al. Sarcoma arising in irradiated bone; report of 11 cases. Cancer. 1948;1(1):3–29.
Arlen M, et al. Radiation-induced sarcoma of bone. Cancer. 1971;28(5):1087–99.
Majeski J, et al. Cutaneous angiosarcoma in an irradiated breast after breast conservation therapy for cancer: association with chronic breast lymphedema. J Surg Oncol. 2000;74(3):208–12; discussion 212–3.
Monroe AT, et al. Angiosarcoma after breast-conserving therapy. Cancer. 2003;97(8):1832–40.
Taghian A, et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys. 1991;21(2):361–7.
Tahir M, et al. Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery. Int Semin Surg Oncol. 2006;3:26.
Vorburger SA, et al. Angiosarcoma of the breast. Cancer. 2005;104(12):2682–8.
Yap J, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(5):1231–7.
West JG, et al. Risk of angiosarcoma following breast conservation: a clinical alert. Breast J. 2005;11(2):115–23.
Pierce SM, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23(5):915–23.
Kirova YM, et al. Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer. 2005;104(4):856–63.
Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.
Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187–220.
Billings SD, et al. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28(6):781–8.
Brenn T, Fletcher CD. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Am J Surg Pathol. 2005;29(8):983–96.
Hui A, et al. Angiosarcoma of the breast: a difficult surgical challenge. Breast. 2012;21(4):584–9.
Scow JS, et al. Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2010;101(5):401–7.
Brady MS, et al. Post-treatment sarcoma in breast cancer patients. Ann Surg Oncol. 1994;1(1):66–72.
Weatherby RP, et al. Postradiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc. 1981;56(5):294–306.
Inoue YZ, et al. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J Surg Oncol. 2000;75(1):42–50.
Manner J, et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol. 2010;176(1):34–9.
Hadj-Hamou NS, et al. A transcriptome signature distinguished sporadic from postradiotherapy radiation-induced sarcomas. Carcinogenesis. 2011;32(6):929–34.
de Jong MA, et al. Reirradiation and hyperthermia for radiation-associated sarcoma. Cancer. 2012;118(1):180–7.
Palta M, et al. Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer. 2010;116(8):1872–8.
Riad S, et al. The clinical and functional outcome for patients with radiation-induced soft tissue sarcoma. Cancer. 2012;118(10):2682–92.
Gladdy RA, et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28(12):2064–9.
Rao J, et al. Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast. J Am Acad Dermatol. 2003;49(3):532–8.
Fury MG, et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11(3):241–7.
Strobbe LJ, et al. Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforseen sequela. Breast Cancer Res Treat. 1998;47(2):101–9.
Pisters PW, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14(5):1679–89.
Zagars GK, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97(10):2530–43.
Yang JC, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16(1):197–203.
Cantin J, et al. The problem of local recurrence after treatment of soft tissue sarcoma. Ann Surg. 1968;168(1):47–53.
Gerner RE, et al. Soft tissue sarcomas. Ann Surg. 1975;181(6):803–8.
Abbas JS, et al. The surgical treatment and outcome of soft-tissue sarcoma. Arch Surg. 1981;116(6):765–9.
Georgiannos SN, Sheaff M. Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook. Br J Plast Surg. 2003;56(2):129–34.
Penel N, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008;26(32):5269–74.
Casper ES, et al. Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Invest. 1998;16(7):442–6.
Fata F, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86(10):2034–7.
Mano MS, et al. Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy. Breast. 2006;15(1):117–8.
Perez-Ruiz E, et al. Response to paclitaxel in a radiotherapy-induced breast angiosarcoma. Acta Oncol. 2009;48(7):1078–9.
Nakamura M, et al. Angiosarcoma with sacral origin metastasizing to the lung. Intern Med. 2006;45(15):923–6.
Gambini D, et al. Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma. Tumori. 2009;95(6):828–31.
Lahat G, et al. Angiosarcoma: clinical and molecular insights. Ann Surg. 2010;251(6):1098–106.
Lahat G, et al. Outcome of locally recurrent and metastatic angiosarcoma. Ann Surg Oncol. 2009;16(9):2502–9.
Nagano T, et al. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer. 2007;110(3):648–51.
Silverman LR, et al. Chemotherapy for angiosarcoma of the breast: case report of 30-year survival and analysis of the literature. Cancer Invest. 1994;12(2):145–55.
Acknowledgment
We thank Sarah Taylor for generous assistance in the identification of cases. This work was supported in part by the Sarcoma Alliance for Research through Collaboration.
Disclosures
There are no conflicts of interest with any financial organization regarding the material discussed in this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Torres, K.E., Ravi, V., Kin, K. et al. Long-Term Outcomes in Patients with Radiation-Associated Angiosarcomas of the Breast Following Surgery and Radiotherapy for Breast Cancer. Ann Surg Oncol 20, 1267–1274 (2013). https://doi.org/10.1245/s10434-012-2755-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-012-2755-y